Concepedia

Toshiaki Tsunenari

TT

20

Publications

805

Citations

17

H-Index

1996

Active since

Affiliations

Chugai Pharma (United States)(Current)

Mochida Pharmaceutical (Japan)

The Cancer Institute Hospital

Toshiaki Tsunenari is an author at Chugai Pharma (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1996–2024

20

Publications

20

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 195 citations

Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity

Hiromitsu Kawata, Nobuyuki Ishikura, Miho Watanabe et al. · The Prostate · 2010 · 64 citations

New Xenograft Model of Multiple Myeloma and Efficacy of a Humanized Antibody Against Human Interleukin-6 Receptor

Toshiaki Tsunenari, Yasuo Koishihara, Akito Nakamura et al. · Blood · 1997 · 63 citations

Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia

Shinsuke Uno, Yasuko Kinoshita, Yumiko Azuma et al. · Oncology Reports · 2007 · 53 citations · Full text

Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974

Hirotake Shiraiwa, Atsushi Narita, Mika Kamata‐Sakurai et al. · Methods · 2018 · 51 citations

, , +10

Rows per page

1–5 of 20